108 related articles for article (PubMed ID: 8392486)
21. Somatostatin receptor imaging: current status and future perspectives.
Bohuslavizki KH
J Nucl Med; 2001 Jul; 42(7):1057-8. PubMed ID: 11438628
[No Abstract] [Full Text] [Related]
22. Evaluation of a radiolabeled somatostatin analog (I-123 octreotide) in the detection and localization of carcinoid and islet cell tumors.
Kvols LK; Brown ML; O'Connor MK; Hung JC; Hayostek RJ; Reubi JC; Lamberts SW
Radiology; 1993 Apr; 187(1):129-33. PubMed ID: 8383865
[TBL] [Abstract][Full Text] [Related]
23. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy.
Lamberts SW; Hofland LJ; van Koetsveld PM; Reubi JC; Bruining HA; Bakker WH; Krenning EP
J Clin Endocrinol Metab; 1990 Sep; 71(3):566-74. PubMed ID: 2168430
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, radiochemistry and biological evaluation of a new somatostatin analogue (SDZ 219-387) labelled with technetium-99m.
Maina T; Stolz B; Albert R; Bruns C; Koch P; Mäcke H
Eur J Nucl Med; 1994 May; 21(5):437-44. PubMed ID: 8062850
[TBL] [Abstract][Full Text] [Related]
25. Somatostatin-receptor imaging for the detection of tumors.
Patel YC
N Engl J Med; 1990 Nov; 323(18):1274-6. PubMed ID: 2170841
[No Abstract] [Full Text] [Related]
26. (2-[18F]fluoropropionyl-(D)phe1)-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: synthesis, radiolabeling, in vitro validation and biodistribution in mice.
Guhlke S; Wester HJ; Bruns C; Stöcklin G
Nucl Med Biol; 1994 Aug; 21(6):819-25. PubMed ID: 9234331
[TBL] [Abstract][Full Text] [Related]
27. Localization of gastroenteropancreatic neuroendocrine tumors with 111indium-pentetreotide scintigraphy.
Pauwels S; Leners N; Fiasse R; Jamar F
Semin Oncol; 1994 Oct; 21(5 Suppl 13):15-20. PubMed ID: 7992075
[No Abstract] [Full Text] [Related]
28. Tissue distribution and metabolism of radioiodinated DTPA0, D-Tyr1 and Tyr3 derivatives of octreotide in rats.
Breeman WA; de Jong M; Bernard B; Hofland LJ; Srinivasan A; van der Pluijm M; Bakker WH; Visser TJ; Krenning EP
Anticancer Res; 1998; 18(1A):83-9. PubMed ID: 9568060
[TBL] [Abstract][Full Text] [Related]
29. Single photon emission computed tomography and positron emission tomography in cancer imaging.
Coleman RE
Cancer; 1991 Feb; 67(4 Suppl):1261-70. PubMed ID: 1991287
[TBL] [Abstract][Full Text] [Related]
30. Specific and high-level targeting of radiolabeled octreotide analogues to human medulloblastoma xenografts.
Vaidyanathan G; Friedman HS; Affleck DJ; Schottelius M; Wester HJ; Zalutsky MR
Clin Cancer Res; 2003 May; 9(5):1868-76. PubMed ID: 12738745
[TBL] [Abstract][Full Text] [Related]
31. [Somatostatin receptor scintigraphy in preoperative diagnosis of the site of endocrine gastrointestinal tumors].
Weinel RJ; Kisker O; Joseph K; Welcke U; Zaraca F; Rothmund M
Chirurg; 1994 Oct; 65(10):849-55. PubMed ID: 7821043
[TBL] [Abstract][Full Text] [Related]
32. Somatostatin receptor-binding peptides labeled with technetium-99m: chemistry and initial biological studies.
Pearson DA; Lister-James J; McBride WJ; Wilson DM; Martel LJ; Civitello ER; Taylor JE; Moyer BR; Dean RT
J Med Chem; 1996 Mar; 39(7):1361-71. PubMed ID: 8691466
[TBL] [Abstract][Full Text] [Related]
33. Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity, and in vivo application in animals.
Bakker WH; Krenning EP; Breeman WA; Koper JW; Kooij PP; Reubi JC; Klijn JG; Visser TJ; Docter R; Lamberts SW
J Nucl Med; 1990 Sep; 31(9):1501-9. PubMed ID: 1975618
[TBL] [Abstract][Full Text] [Related]
34. Visualisation of a somatostatin receptor-expressing tumour with 67Ga-DOTATOC SPECT.
Zhernosekov K; Aschoff P; Filosofov D; Jahn M; Jennewein M; Adrian HJ; Bihl H; Rösch F
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1129. PubMed ID: 16133389
[No Abstract] [Full Text] [Related]
35. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.
Krenning EP; Bakker WH; Kooij PP; Breeman WA; Oei HY; de Jong M; Reubi JC; Visser TJ; Bruns C; Kwekkeboom DJ
J Nucl Med; 1992 May; 33(5):652-8. PubMed ID: 1349039
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of somatostatin receptors in human cancer.
Pantev T; Virgolini I; Neuhold N; Angelberger P; Luger A; Sinzinger H
Wien Klin Wochenschr; 1991; 103(21):649-53. PubMed ID: 1663300
[TBL] [Abstract][Full Text] [Related]
37. Biodistribution, blood half-life, and receptor binding of a somatostatin-dextran conjugate.
Behe M; Du J; Becker W; Behr T; Angerstein C; Márquez M; Hiltunen J; Nilsson S; Holmberg AR
Med Oncol; 2001; 18(1):59-64. PubMed ID: 11778971
[TBL] [Abstract][Full Text] [Related]
38. Characterization of somatostatin receptors on human neuroblastoma tumors.
O'Dorisio MS; Chen F; O'Dorisio TM; Wray D; Qualman SJ
Cell Growth Differ; 1994 Jan; 5(1):1-8. PubMed ID: 8123588
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity in hepatic transport of somatostatin analog octapeptides.
Fricker G; Dubost V; Schwab D; Bruns C; Thiele C
Hepatology; 1994 Jul; 20(1 Pt 1):191-200. PubMed ID: 8020889
[TBL] [Abstract][Full Text] [Related]
40. Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy.
Lewis JS; Lewis MR; Srinivasan A; Schmidt MA; Wang J; Anderson CJ
J Med Chem; 1999 Apr; 42(8):1341-7. PubMed ID: 10212119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]